Original paper

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

Volume: 27, Issue: 6, Pages: 381 - 399
Published: Jun 1, 2010
Abstract
This pooled analysis of data from three phase 3 studies in patients with chronic osteoarthritis knee or low back pain evaluated the efficacy and tolerability of tapentadol prolonged release (PR; 100–250 mg twice daily) compared with placebo and oxycodone hydrochloride (HCl) controlled release (CR; 20–50 mg twice daily). Patients in each study were randomized to receive twice-daily doses of placebo, tapentadol PR (100–250 mg), or oxycodone HCl CR...
Paper Details
Title
Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain
Published Date
Jun 1, 2010
Volume
27
Issue
6
Pages
381 - 399
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.